Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has transformed weight loss expectations for millions of people, but understanding realistic weekly progress helps set sustainable goals. Clinical trials show that participants lose an average of 15% of body weight over 68 weeks, translating to roughly 0.5 to 2 pounds per week depending on starting weight and individual metabolism. Your genetic makeup plays a critical role in how your body responds to this medication.
Average Weekly Weight Loss on Semaglutide Therapy
Most people taking semaglutide experience weight loss that accelerates gradually as their dose increases from the starter phase through the maintenance phase. During the first four weeks at the lowest dose (0.25 mg), weight loss is typically modest—often 1 to 3 pounds total rather than per week. By weeks 5 through 12, as the dose reaches 0.5 mg and higher, weekly losses often climb to 1 to 2 pounds per week for many patients.
Body composition and starting weight significantly influence weekly numbers. A person starting at 250 pounds may see 2+ pounds per week initially, while someone closer to their goal weight might experience 0.5 to 1 pound weekly. These variations reflect how semaglutide works: it reduces hunger signals and slows stomach emptying, creating a calorie deficit that becomes more pronounced as your dose stabilizes.
How Genetics Determine Your Individual Response
Your genetic variants in key appetite-regulation pathways—such as the GLP1R gene (rs6923761) and the GIPR pathway (rs1800437)—determine how effectively your body responds to semaglutide signaling. Someone with a favorable genetic profile for GLP-1 sensitivity may achieve closer to 2 pounds per week, while others may stabilize at 0.5 to 1 pound weekly even at higher doses. The PlexusDx Precision Peptide Genetic Test identifies these variants across 14 metabolic pathways and 49 peptides to predict your personal response.
Additional genes like FTO (rs9939609) and MC4R (rs17782313) influence appetite baseline and energy expenditure. Understanding your genetic predispositions allows PlexusDx to recommend whether standard semaglutide, higher-dose protocols, or dual-compound therapies (like GLP-Squared) may optimize your weekly progress. This personalized approach removes guesswork from your weight loss timeline.
Factors That Slow or Speed Up Weekly Weight Loss
Consistent calorie intake, physical activity level, sleep quality, and hormone balance directly influence how many pounds you lose each week on semaglutide. The medication suppresses appetite and increases satiety, but your daily food choices and portion sizes still matter. Someone eating 500 calories below maintenance will see faster weekly losses than someone in a smaller deficit, even on identical semaglutide doses.
Metabolic adaptation also plays a role: your body naturally becomes more efficient at conserving energy as weight loss progresses, which can slow weekly losses after the initial 8 to 12 weeks. This plateau is normal and expected. PlexusDx clients often benefit from periodic dose increases or protocol adjustments to maintain momentum, guided by their genetic testing insights and clinical progress tracking.
Comparing Semaglutide to Other GLP-1 Options
Semaglutide injections delivered weekly are the most studied GLP-1 therapy, with robust real-world data supporting 0.5 to 2 pounds weekly weight loss in most patients. Oral semaglutide and tirzepatide (a dual GLP-1/GIP agonist) can produce similar or sometimes faster weekly losses, particularly in people with genetic variants favoring GIP-receptor sensitivity. PlexusDx offers all three options—Compounded Semaglutide Injection starting at $149/month, Oral Semaglutide at $249/month, and Compounded Tirzepatide Injection at $249/month—all from licensed 503A compounding pharmacies and available across all 50 states without insurance.
For patients with unfavorable response profiles to semaglutide alone, PlexusDx's GLP-Squared dual-compound injection (semaglutide plus tirzepatide, starting at $249/month) may accelerate weekly losses by targeting both GLP-1 and GIP pathways. Your Precision Peptide Genetic Test results guide which protocol has the strongest evidence for your specific genetic background.
Setting Realistic Expectations for Sustainable Loss
Losing 1 to 2 pounds per week is considered healthy, sustainable weight loss by most medical standards. Faster losses, while initially gratifying, often lead to muscle loss, nutritional deficiencies, and rebound weight gain once medication is paused. PlexusDx recommends focusing on cumulative progress over 12 to 24 weeks rather than chasing dramatic weekly numbers, as this builds lasting lifestyle changes alongside pharmacotherapy.
Many patients report that the psychological benefit of consistent weekly progress outweighs the actual pound amount: predictable, steady weight loss motivates adherence and reinforces the medication's appetite-suppressing effects. Your clinical team reviews weekly or monthly progress and adjusts dosing—your price remains flat at $149 to $289 per month depending on your chosen tier, regardless of dose level.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I expect to lose 5 pounds a week on semaglutide like I've heard some people do?
Losing 5 pounds per week would represent unsustainable water and muscle loss rather than fat loss. Most clinical data shows 0.5 to 2 pounds of fat loss weekly on semaglutide, with faster losses typically occurring in the first 4 to 8 weeks when water weight drops alongside fat. PlexusDx supports gradual, clinically proven weight loss that protects muscle mass and metabolism.
What does research actually say about semaglutide's weekly weight loss?
The STEP trials, the largest clinical studies of semaglutide for weight loss, documented average weight loss of 15% of body weight over 68 weeks—roughly 1 to 1.5 pounds weekly for most participants. Real-world data from telehealth and compounding pharmacy programs confirms similar ranges. Your individual results depend on genetic factors, adherence, and lifestyle, which PlexusDx personalizes through genetic testing.
Is PlexusDx semaglutide cheaper than Wegovy, and will my weekly results differ?
PlexusDx Compounded Semaglutide Injection starts at $149 per month from licensed 503A compounding pharmacies, significantly lower than brand-name Wegovy. Weekly weight loss results depend on your genetics, dose protocol, and adherence—not the manufacturer. Your dose may go up, but your price won't, and you access treatment without insurance across all 50 states.
Are there safety concerns if I'm losing more than 2 pounds per week?
Losses exceeding 2 pounds weekly raise flags for muscle loss, dehydration, and nutrient gaps. Your PlexusDx clinical team monitors progress and adjusts dosing to maintain safe, sustainable weight loss. If you're experiencing very rapid loss or side effects, contact your provider to ensure your protocol is optimized for your genetics and health status.
How can the Precision Peptide Genetic Test predict my weekly weight loss on semaglutide?
PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and variants like GLP1R, GIPR, FTO, and MC4R to predict how strongly your body responds to semaglutide's appetite signals. This 150+ genetic insight profile helps your clinician estimate realistic weekly losses for your biology and recommend whether semaglutide, tirzepatide, or dual-compound therapy will optimize your results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss with Wegovy and a Hiatal Hernia: Your Path to Health
Navigating Ozempic Prior Authorization: How Long Does It Really Take?